About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Sirt1tm1.1Cxd
targeted mutation 1.1, Chu-Xia Deng
MGI:3812143
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Sirt1tm1.1Cxd/Sirt1tm1.1Cxd either: (involves: 129S6/SvEvTac * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * C57BL/6 * FVB/N) MGI:3812160
ht2
Sirt1tm1.1Cxd/Sirt1+ either: (involves: 129S6/SvEvTac * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * C57BL/6 * FVB/N) MGI:3812163
cx3
Sirt1tm1.1Cxd/Sirt1tm1.1Cxd
Trp53tm1Brd/Trp53tm1Brd
either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N) MGI:3812167
cx4
Sirt1tm1.1Cxd/Sirt1tm1.1Cxd
Trp53tm1Brd/Trp53+
either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N) MGI:3812169
cx5
Sirt1tm1.1Cxd/Sirt1+
Trp53tm1Brd/Trp53+
either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N) MGI:3812172


Genotype
MGI:3812160
hm1
Allelic
Composition
Sirt1tm1.1Cxd/Sirt1tm1.1Cxd
Genetic
Background
either: (involves: 129S6/SvEvTac * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sirt1tm1.1Cxd mutation (0 available); any Sirt1 mutation (78 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• Background Sensitivity: the survival rate to adulthood on a 129S6/SvEv FVB background is 1% while the survival rate on a 129S6/SvEv FVB Black Swiss is 9.3%
• nearly all mice die between E14.5 and E16.5

cellular
• cells from E9.5 mice exhibit chromosomal abnormalities including aneuploidy, broken chromosomes and less condensed chromosomes
• heterochromatin formation is impaired
• in 37% of mouse embryo fibroblasts
• following treatment with low dose of gamma irradiation, mouse embryonic fibroblasts exhibit a defect in the G1/S checkpoint
• however, at high doses of radiation the G1/S checkpoint functions normally
• embryos exhibit an increase in the number of cells in the early phase of mitosis
• embryos exhibit an increase in the number of cells positive for markers of cell death
• survival of mouse embryonic fibroblasts followed exposure to gamma radiation is decrease compared to in similarly treated wild-type cells
• survival of mouse embryonic fibroblasts followed exposure to UV radiation is decrease compared to in similarly treated wild-type cells
• mouse embryonic fibroblasts exhibit reduced microhomologous DNA damage repair ability compared to in wild-type cells
• mouse embryonic fibroblasts exhibit defects in repair of UV irradiation damage
• however, less precise ligation and end joining is normal
• 37% of mouse embryo fibroblasts exhibit lagging chromosomes and unequal segregation during replication

embryo
• most embryos at E10.5 to E12.5
• at E11.25, some mice lack hindlimb buds

growth/size/body
• most embryos at E10.5 to E12.5
• in some surviving mice at E11.25

homeostasis/metabolism
• mouse embryonic fibroblasts exhibit reduced microhomologous DNA damage repair ability compared to in wild-type cells
• mouse embryonic fibroblasts exhibit defects in repair of UV irradiation damage
• however, less precise ligation and end joining is normal
• 37% of mouse embryo fibroblasts exhibit lagging chromosomes and unequal segregation during replication

limbs/digits/tail
• at E11.25, some mice lack hindlimb buds




Genotype
MGI:3812163
ht2
Allelic
Composition
Sirt1tm1.1Cxd/Sirt1+
Genetic
Background
either: (involves: 129S6/SvEvTac * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sirt1tm1.1Cxd mutation (0 available); any Sirt1 mutation (78 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• in some mice




Genotype
MGI:3812167
cx3
Allelic
Composition
Sirt1tm1.1Cxd/Sirt1tm1.1Cxd
Trp53tm1Brd/Trp53tm1Brd
Genetic
Background
either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sirt1tm1.1Cxd mutation (0 available); any Sirt1 mutation (78 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• only one mouse survives birth
• no mice are alive at weaning
• fewer than expected mice are alive at E15.5




Genotype
MGI:3812169
cx4
Allelic
Composition
Sirt1tm1.1Cxd/Sirt1tm1.1Cxd
Trp53tm1Brd/Trp53+
Genetic
Background
either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sirt1tm1.1Cxd mutation (0 available); any Sirt1 mutation (78 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 5 mice are alive at weaning
• fewer than expected mice survive to birth
• fewer than expected mice are alive at E15.5




Genotype
MGI:3812172
cx5
Allelic
Composition
Sirt1tm1.1Cxd/Sirt1+
Trp53tm1Brd/Trp53+
Genetic
Background
either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sirt1tm1.1Cxd mutation (0 available); any Sirt1 mutation (78 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• tumors exhibit extensive aneuploidy and chromosomal aberrations, notably translocations, chromosome breaks, deletions and dicentric chromosomes
• mice begin to develop tumors at 5 months of age with tumor incidence reaching 76% by 20 months of age compared to only 2 of 21 Sirt1tm1.1Cxd heterozygotes and 3 of 23 Trp53tm1Brd heterozygotes
• however, treatment of mice with resveratrol decreases the incidence of tumors and delays onset
• 35% of tumors are lymphomas
• 16% of tumors are carcinomas
• 46% of tumors are sarcomas
• 22% of tumors are teratomas





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory